ABCL
AbCellera Biologics Inc. Common Shares
$5.97
2.93%
+0.17
Notify me if price changes either direction
Buy ABCL stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
1.8B
Enterprise value
1.4B
Trailing PE
-12.173469699159
Forward PE
-8.226951
PEG Ratio
1.8260204548738
Enterprise to EBITDA
-7.471
Enterprise to revenue
17.759
Price to book MRQ
1.8794557
Price to sales TTM
22.361092
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-03-31
Revenue (TTM)
79.2M
EBITDA
-188284000
Diluted EPS TTM
-0.43
Total Cash (MRQ)
504.7M
Current ratio (MRQ)
14.052
Operating Cash Flow (TTM)
-153264000
ABCL trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
July 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
